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Dear Sir,
We read with interest the recent article by Toledo et al. [1]. In
their study, the authors found that mRNA levels for SIRT1
were increased in muscle from tumor-bearing rats and that
SIRT3mRNA levels were unchanged. In the discussion of the
results, the authors stated that the observation of unchanged
SIRT3 “is in contrast with that of Alamdari et al. [39] showing
an upregulation of SIRT3 in skeletal muscle during sepsis”.
This was a surprising statement since we did not examine or
report on SIRT3 expression in our study [2]. We did examine
the effects of sepsis on the mRNA levels for the histone
deacetylases HDAC3 and 6 and nuclear protein levels for
the same HDACs as well as for SIRT1. Importantly, protein
levels for HDAC6 and SIRT1 were decreased (not increased)
and muscle HDAC activity was reduced during sepsis.
We think the misquotation of our work in the article by
Toledo et al. [1] was unfortunate, not only because it was
erroneous but also because it suggests that the expression of
a histone deacetylase (SIRT3) may be increased during
sepsis, implying increased deacetylase activity and reduced
levels of acetylated cellular proteins. This is opposite to the
conclusions in our paper [2] and in other recent reports from
our laboratory [3–7] in which we found evidence that mus-
cle wasting caused by sepsis and glucocorticoids is associ-
ated with, and probably at least in part regulated by
increased acetylation of cellular proteins. These conclusions
were also supported by experiments in which treatment of
cultured muscle cells [4] or rats in vivo [2] with histone
deacetylase inhibitor increased the expression of atrogin-1 and
stimulated protein breakdown. In more recent experiments,
we found evidence for a role of reduced (not increased) SIRT1
expression and activity in glucocorticoid-induced muscle
wasting [7]. It was surprising to see that SIRT1 mRNA levels
were increased in muscle from tumor-bearing rats in the study
by Toledo et al. [1]. It would have been interesting to have
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